查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1571469

西方印漬術市場規模、佔有率、趨勢分析報告：按類型、應用、最終用途、地區、細分市場預測，2024-2030 年

Western Blotting Market Size, Share & Trends Analysis Report, By Type (Instruments), By Application (Biomedical & Biochemical Research, Disease Diagnostics), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

西方印漬術市場的成長與趨勢：

根據 Grand View Research, Inc. 的最新報告，預計到 2030 年，全球西方印漬術市場規模將達到 14.8 億美元，2024 年至 2030 年複合年成長率為 6.1%。

感染愛滋病毒的人數不斷增加，對市場的成長做出了越來越大的貢獻。這種類型的測試對於檢測人群中的愛滋病毒非常有效。根據聯合國愛滋病規劃署的數據，2015 年全球有近 3,670 萬人感染愛滋病毒。如此高的愛滋病毒感染率預計將加速對用於西方印漬術的產品的需求。萊姆病也需要西方印漬術來檢測導致此類疾病的伯氏疏螺旋體 (Bb)。其他需要蛋白質印跡檢測特定蛋白質的疾病包括狂牛症、肝炎和貓免疫力缺乏。

此外，製藥和生物技術公司對研發活動的大量投資預計將推動西方印漬術市場的成長。根據新聞日誌報道，生技公司 2015 年在研發活動上花費了 401 億美元，比 2014 年的投資成長了 16%。因此，隨著研究和開發活動的增加，預計在不久的將來對西方印漬術測試的需求將會增加。

西方印漬術市場報告亮點

  • 2023 年，消耗品領域以 68.1% 的佔有率佔據市場主導地位。由於西方印漬術方法的敏感度、效率和特異性不斷提高，耗材領域實現了巨大的需求。
  • 疾病診斷領域主導西方印漬術市場，2023年銷售佔有率為60.4%。 V因子、皰疹症狀病毒（HSV）、B型肝炎病毒（HBV）、萊姆病、癌症等慢性疾病和自體免疫疾病發生率的增加是推動該細分市場成長的因素。
  • 製藥和生物技術公司細分市場佔據主導地位，2023 年收益佔有率為 32.0%。對標靶治療、個人化醫療的日益關注以及對藥物發現的投資增加正在促進細分市場的成長。
  • 北美西方印漬術市場在全球市場中佔據主導地位，2023 年收益佔有率為 41.8%。區域製造公司的存在、蛋白質體學研究投資的增加以及個人化醫療意識的增強正在推動成長。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章西方印漬術市場變數、趨勢、範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 西方印漬術市場分析工具
    • 波特的分析
    • PESTEL分析

第4章西方印漬術市場：類型估計和趨勢分析

  • 細分儀表板
  • 西方印漬術市場：類型變化分析，百萬美元，2023-2030 年
  • 裝置
  • 消耗品

第5章西方印漬術市場：應用評估與趨勢分析

  • 細分儀表板
  • 西方印漬術市場：應用變化分析，百萬美元，2023-2030 年
  • 生物醫學/生化研究
  • 疾病診斷
    • HIV
    • 萊姆病
    • 肝炎
    • 其他疾病
  • 農業
  • 其他

第6章西方印漬術市場：最終用途估計和趨勢分析

  • 細分儀表板
  • 西方印漬術市場：最終用途變異分析，百萬美元，2023-2030
  • 學術/研究機構
  • 製藥和生物技術公司
  • 診斷中心
  • 其他

第7章西方印漬術市場：區域估計和趨勢分析

  • 西方印漬術市場佔有率（按地區），2023 年和 2030 年，百萬美元
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 科威特

第8章 競爭格局

  • 最新趨勢與影響分析：主要市場參與企業
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Thermo Fisher Scientific, Inc.
    • Bio-Rad Laboratories, Inc.
    • LI-COR Biosciences Inc.
    • Merck KGaA
    • F. Hoffmann-La Roche Ltd
    • Bio-Techne Corporation
    • GE HealthCare
    • PerkinElmer, Inc.
    • Advansta, Inc.
    • Cell Signaling Technology
簡介目錄
Product Code: GVR-1-68038-709-4

Western Blotting Market Growth & Trends:

The global western blotting market size is expected to reach USD 1.48 billion by 2030, registering a CAGR of 6.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising number of cases with HIV are increasingly contributing towards the growth of market. This kind of testing is highly effective in detecting HIV among people. According to UNAIDS, nearly 36.7 million people were living with HIV throughout the world in 2015. Such high prevalence of HIV is expected to accelerate the demand for products used in western blotting. Lyme diseases also require western blotting to detect Borrelia burgdorferi (Bb), which causes such diseases. Other diseases which require western blot for detection of specific proteins include mad cow disease, hepatitis, and feline immunodeficiency.

Moreover, significant investments in R&D activities made by pharmaceutical and biotechnology companies are expected to foster growth of western blotting market. According to a news journal, biotech companies spent USD 40.1 billion in 2015 on R&D activities, which was a 16% rise from their 2014 investments. Hence, with rising number of R&D activities, there is an expected rise in the demand for western blotting tests in the near future.

Western Blotting Market Report Highlights:

  • The consumables segment dominated the market with a share of 68.1% in 2023. The consumables segment witnessed a significant demand based on the augmented sensitivity, efficiency, and specificity of the western blotting method.
  • The disease diagnostics segment dominated the western blotting market with a revenue share of 60.4% in 2023. The growing incidences of Factor V, Herplex Symptoms Virus (HSV), Hepatitis B Virus (HBV), and Lyme sickness, incidences of chronic diseases such as cancers, and autoimmune disorders account for segment growth.
  • The pharmaceutical and biotechnology companies segment dominated the market with a revenue share of 32.0% in 2023. The growing focus on targeted treatment, personalized medicine, and increasing investment in drug discovery contribute to the segment growth.
  • North America western blotting market dominated the global market with a revenue share of 41.8% in 2023. The presence of manufacturing companies in the region, growing investment in proteomics studies, and a growing awareness of customized medicine encourage growth.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Western Blotting Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Western Blotting Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Western Blotting Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Western Blotting Market: Type Movement Analysis, USD Million, 2023 & 2030
  • 4.3. Instruments
    • 4.3.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Gel Electrophoresis Instruments
      • 4.3.2.1. Gel Electrophoresis Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Blotting Systems
      • 4.3.3.1. Blotting Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.3.2. Semi-Dry Blotting Instruments
        • 4.3.3.2.1. Semi-Dry Blotting Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.3.3. Wet Blotting Instruments
        • 4.3.3.3.1. Wet Blotting Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. Imagers
      • 4.3.4.1. Imagers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.4.2. Chemiluminescent Imagers
        • 4.3.4.2.1. Chemiluminescent Imagers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.4.3. Fluorescent Imagers
        • 4.3.4.3.1. Fluorescent Imagers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.5. Others
      • 4.3.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Consumables
    • 4.4.1. Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Reagents and Buffers
      • 4.4.2.1. Reagents and Buffers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Antibodies and Conjugates
      • 4.4.3.1. Antibodies and Conjugates Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Primary Antibodies
      • 4.4.4.1. Primary Antibodies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.4.2. Secondary Antibodies
        • 4.4.4.2.1. Secondary Antibodies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.5. Other Antibodies and Conjugates
      • 4.4.5.1. Other Antibodies and Conjugates Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.6. Kits
      • 4.4.6.1. Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.7. Membranes and Filters
      • 4.4.7.1. Membranes and Filters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.8. Other Consumables
      • 4.4.8.1. Other Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Western Blotting Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Western Blotting Market: Application Movement Analysis, USD Million, 2023 & 2030
  • 5.3. Biomedical & Biochemical Research
    • 5.3.1. Biomedical & Biochemical Research Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Disease Diagnostics
    • 5.4.1. Disease Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. HIV
      • 5.4.2.1. HIV Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. Lyme Disease
      • 5.4.3.1. Lyme Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.4. Hepatitis
      • 5.4.4.1. Hepatitis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.5. Other Diseases
      • 5.4.5.1. Other Diseases Market Revenue Estimates and Forecasts, 2018 -2030 (USD Million)
  • 5.5. Agriculture
    • 5.5.1. Agriculture Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Western Blotting Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Western Blotting Market: End Use Movement Analysis, USD Million, 2023 & 2030
  • 6.3. Academic & Research Institutes
    • 6.3.1. Academic & Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Pharmaceutical & Biotechnology Companies
    • 6.4.1. Pharmaceutical & Biotechnology Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Diagnostic Centers
    • 6.5.1. Diagnostic Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Western Blotting Market: Regional Estimates & Trend Analysis

  • 7.1. Western Blotting Market Share, By Region, 2023 & 2030, USD Million
  • 7.2. North America
    • 7.2.1. North America Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. France Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Italy Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Spain Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Sweden Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Norway Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. China
      • 7.4.2.1. China Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Japan Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. India Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Australia Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Thailand Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Saudi Arabia
      • 7.6.2.1. Saudi Arabia Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. UAE
      • 7.6.3.1. UAE Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. South Africa
      • 7.6.4.1. South Africa Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. Thermo Fisher Scientific, Inc.
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/ Strategic Initiatives
    • 8.4.2. Bio-Rad Laboratories, Inc.
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/ Strategic Initiatives
    • 8.4.3. LI-COR Biosciences Inc.
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/ Strategic Initiatives
    • 8.4.4. Merck KGaA
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/ Strategic Initiatives
    • 8.4.5. F. Hoffmann-La Roche Ltd
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/ Strategic Initiatives
    • 8.4.6. Bio-Techne Corporation
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/ Strategic Initiatives
    • 8.4.7. GE HealthCare
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/ Strategic Initiatives
    • 8.4.8. PerkinElmer, Inc.
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/ Strategic Initiatives
    • 8.4.9. Advansta, Inc.
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/ Strategic Initiatives
    • 8.4.10. Cell Signaling Technology
      • 8.4.10.1. Participant's Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Recent Developments/ Strategic Initiatives